Innovative application of allosteric modulators of adenosine a1 receptors for the prevention and treatment of stroke and myocardial infarction

Projektinformationen

KOUROUNAKIS ANGELIKI

ID Finanzhilfevereinbarung: QLK6-CT-1999-51170

Projekt abgeschlossen

Startdatum 17 Januar 2000

Enddatum 16 Januar 2001

Finanziert unter

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Gesamtkosten € 51 600,00

EU-Beitrag € 51 600,00

Koordiniert durch

ARISTOTLE UNIVERSITY OF THESSALONIKI
Greece

Ziel

Evaluation of a novel series of allosteric modulators, compounds that enhance adenosine A1 agonist binding and function, in combination with antioxidants, in in-vitro/in-vivo models of ischemic-reperfusion injury.

Wissenschaftliches Gebiet

• medical and health sciences › basic medicine › neurology › stroke

Programm/Programme

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Thema/Themen

• 1.1.1.-6. - Key action The Ageing Population and Disabilities

Aufforderung zur Vorschlagseinreichung

Data not available

Finanzierungsplan

RGI - Research grants (individual fellowships)

Koordinator

ARISTOTLE UNIVERSITY OF THESSALONIKI

• EU-Beitrag: Keine Daten
• Adresse: University Building Administration Building ; 54006 THESSALONKI ; Griechenland
• Gesamtkosten: Keine Daten